Revised: 7 April 2014

Committees

Comments on Agenda Items for the 51st Medicines Classification Committee meeting

A total of 18 comments on agenda items for the 51st meeting were received. (PDF Document 6646KB - 60 pages)

Six comments were received regarding the objection to the reclassification of sildenafil.

15 comments were received regarding the proposed reclassification of oral contraceptives.

Two comments were received regarding the proposed reclassification of diclofenac.

Two comments were received regarding the proposed reclassification of oxymetazoline.